So far, discontinuous named entity recognition (NER) has received increasing research attention and many related methods have surged such as hypergraph-based methods, span-based methods, and sequence-to-sequence (Seq2Seq) methods, etc. However, these methods more or less suffer from some problems such as decoding ambiguity and efficiency, which limit their performance. Recently, grid-tagging methods, which benefit from the flexible design of tagging systems and model architectures, have shown superiority to adapt for various information extraction tasks. In this paper, we follow the line of such methods and propose a competitive grid-tagging model for discontinuous NER. We call our model TOE because we incorporate two kinds of Tag-Oriented Enhancement mechanisms into a state-of-the-art (SOTA) grid-tagging model that casts the NER problem into word-word relationship prediction. First, we design a Tag Representation Embedding Module (TREM) to force our model to consider not only word-word relationships but also word-tag and tag-tag relationships. Concretely, we construct tag representations and embed them into TREM, so that TREM can treat tag and word representations as queries/keys/values and utilize self-attention to model their relationships. On the other hand, motivated by the Next-Neighboring-Word (NNW) and Tail-Head-Word (THW) tags in the SOTA model, we add two new symmetric tags, namely Previous-Neighboring-Word (PNW) and Head-Tail-Word (HTW), to model more fine-grained word-word relationships and alleviate error propagation from tag prediction. In the experiments of three benchmark datasets, namely CADEC, ShARe13 and ShARe14, our TOE model pushes the SOTA results by about 0.83%, 0.05% and 0.66% in F1, demonstrating its effectiveness.
BACKGROUND Hypoglycemic events are common and potentially dangerous conditions among patients being treated for diabetes. Automatic detection of such events could improve patient care and is valuable in population studies. Electronic health records (EHRs) are valuable resources for the detection of such events. OBJECTIVE In this study, we aim to develop a deep-learning–based natural language processing (NLP) system to automatically detect hypoglycemic events from EHR notes. Our model is called the High-Performing System for Automatically Detecting Hypoglycemic Events (HYPE). METHODS Domain experts reviewed 500 EHR notes of diabetes patients to determine whether each sentence contained a hypoglycemic event or not. We used this annotated corpus to train and evaluate HYPE, the high-performance NLP system for hypoglycemia detection. We built and evaluated both a classical machine learning model (ie, support vector machines [SVMs]) and state-of-the-art neural network models. RESULTS We found that neural network models outperformed the SVM model. The convolutional neural network (CNN) model yielded the highest performance in a 10-fold cross-validation setting: mean precision=0.96 (SD 0.03), mean recall=0.86 (SD 0.03), and mean F1=0.91 (SD 0.03). CONCLUSIONS Despite the challenges posed by small and highly imbalanced data, our CNN-based HYPE system still achieved a high performance for hypoglycemia detection. HYPE can be used for EHR-based hypoglycemia surveillance and population studies in diabetes patients.
BACKGROUND Pharmacovigilance and drug-safety surveillance are crucial for monitoring adverse drug events (ADEs), but the main ADE-reporting systems such as Food and Drug Administration Adverse Event Reporting System face challenges such as underreporting. Therefore, as complementary surveillance, data on ADEs are extracted from electronic health record (EHR) notes via natural language processing (NLP). As NLP develops, many up-to-date machine-learning techniques are introduced in this field, such as deep learning and multi-task learning (MTL). However, only a few studies have focused on employing such techniques to extract ADEs. OBJECTIVE We aimed to design a deep learning model for extracting ADEs and related information such as medications and indications. Since extraction of ADE-related information includes two steps—named entity recognition and relation extraction—our second objective was to improve the deep learning model using multi-task learning between the two steps. METHODS We employed the dataset from the Medication, Indication and Adverse Drug Events (MADE) 1.0 challenge to train and test our models. This dataset consists of 1089 EHR notes of cancer patients and includes 9 entity types such as Medication, Indication, and ADE and 7 types of relations between these entities. To extract information from the dataset, we proposed a deep-learning model that uses a bidirectional long short-term memory (BiLSTM) conditional random field network to recognize entities and a BiLSTM-Attention network to extract relations. To further improve the deep-learning model, we employed three typical MTL methods, namely, hard parameter sharing, parameter regularization, and task relation learning, to build three MTL models, called HardMTL, RegMTL, and LearnMTL, respectively. RESULTS Since extraction of ADE-related information is a two-step task, the result of the second step (ie, relation extraction) was used to compare all models. We used microaveraged precision, recall, and F1 as evaluation metrics. Our deep learning model achieved state-of-the-art results (F1=65.9%), which is significantly higher than that (F1=61.7%) of the best system in the MADE1.0 challenge. HardMTL further improved the F1 by 0.8%, boosting the F1 to 66.7%, whereas RegMTL and LearnMTL failed to boost the performance. CONCLUSIONS Deep learning models can significantly improve the performance of ADE-related information extraction. MTL may be effective for named entity recognition and relation extraction, but it depends on the methods, data, and other factors. Our results can facilitate research on ADE detection, NLP, and machine learning.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.